ABRUPT: Toxicity and quality of life with dose-escalated SBRT using The Raypilot System

Prospective study of ablative radiotherapy for unfavourable prostate tumours with The Raypilot System, using one single fraction. Reports toxicity rates and quality-of-life outcomes at dose escalation.

Why it matters: Raypilot System-specific clinical data. Measured outcomes from patients treated with this system in routine clinical practice.